Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) with p < .05 and [logFC] > 1 were identified. Functional enrichment, protein-protein interaction network construction and survival analyses were then performed. First, 51 upregulated and 78 downregulated DEGs shared between the two GSE datasets were identified. Second, functional enrichment analysis showed that these DEGs are mainly involved in the B cell receptor signaling pathway, hematopoietic cell lineage, and NF-kappa B pathway. Moreover, interrelation analysis of immune system processes showed enrichment of the downregulated DEGs mainly in B cell differentiation, positive regulation of monocyte chemotaxis and positive regulation of T cell proliferation. Finally, the correlation between DEG expression and survival in MM was evaluated using the PrognoScan database. In conclusion, we identified key candidate genes that affect the outcomes of patients with MM, and these genes might serve as potential therapeutic targets.
single cohort study, creating poor reproducibility and consistency. To overcome these disadvantages, integrated bioinformatics methods should be combined with expression profiling techniques.
In the current study, we downloaded two microarray datasets, GSE6477 and GSE47552 (Lopez-Corral et al., 2014) , from the NCBI-Gene Expression Omnibus database (NCBI-GEO), including gene expression data for purified plasma cell samples from 110 patients with MM and 20 healthy controls. We identified differentially expressed genes (DEGs) using the interactive web tool GEO2R with standard data processing and analyzed these DEGs were performed Gene Ontology (GO) and pathway enrichment analysis with the Database for Annotation, Visualization and Integrated Discovery (DAVID), KEGG pathways and REACTOME.
Subsequently, we integrated the DEG protein-protein interaction (PPI) network with module screening to identify hub genes in MM.
Identifying DEGs and enriching their functions and signaling pathways may help reveal potential biosignatures for the diagnosis and management of MM.
| MATERIALS AND METHODS

| Microarray data information and DEG identification
The gene expression profiles GSE6477 and GSE47552 were obtained from NCBI-GEO. The microarray data of GSE6477 are based on GPL96 platforms (HG-U133A Affymetrix Human Genome U133A Array) and include purified plasma cell samples from 69 newly diagnosed patients with MM and 15 healthy controls. The GSE47552 data are based on GPL6244 platforms (HuGene-1_0-st Affymetrix Human Gene 1.0 ST Array) and include purified plasma cell samples from 41 newly diagnosed MM patients and 5 healthy controls.
GEO2R was used to identify DEGs between patients with MM and healthy controls. In this study, genes with p < .05 and [logFC] > 1 were defined as DEGs. The DEG data were processed at the Morpheus website (available online: https://software.broadinstitute.org/morpheus) to draw a heatmap of the top 100 significantly changed genes.
2.2 | GO and pathway enrichment analysis DAVID (https://david-d.ncifcrf.gov/) was used to analyze candidate DEG functions and KEGG pathway enrichment. GO term enrichment analysis includes biological process (BP), cellular component (CC), and molecular function (MF). Pathway analysis was also carried out using another online database, REACTOME (available online: http://www.reactome. org). Interrelation analysis between pathways was developed using the ClueGo plug-in Cytoscape software. A p value <.05 was considered the cut-off criterion.
| PPI network establishment and modular analysis
We evaluated the DEG-encoded proteins and PPI information using the STRING database (available online: http://string-db.org). Cytoscape software version 3.7.1 was applied to establish the protein interaction network. MCODE, a plug-in in Cytoscape, was utilized to screen the modules from the PPI network and identify the most significant module based on the MCODE score and node number.
| Survival analysis
Correlation between DEG expression and survival in MM was analyzed using the PrognoScan database (http://dna00.bio.kyutech. ac.jp/PrognoScan/). PrognoScan searches for relationships between gene expression and MM disease-specific survival (DSS) were based on the GSE2658 data set (n = 559). A Cox p value <.05 was considered statistically significant.
| RESULTS
| Identification of DEGs in MM
We obtained gene expression profiles of purified plasma cell samples from newly diagnosed patients with MM and healthy controls from the GSE6477 and GSE47552 datasets and analyzed DEGs using GEO2R. Setting the cut-off criterion as p < .05 and [logFC] > 1, we identified 1,266 and 871 DEGs from GSE6477 and GSE47552, respectively ( Figure 1a ). Figure 1b shows the top 100 genes depicted as a heatmap. These genes were well clustered between patients with MM and healthy controls. Employing integrated bioinformatics analysis, we identified 51 upregulated genes and 78 downregulated genes as common to the two datasets ( Figure 1c ).
| GO term enrichment analysis of DEGs
We performed DEG GO analysis using the DAVID gene annotation tool. As shown in Figure 2a , the DEGs were examined according to three subontologies: BP, CC, and MF. Figure 2b and Table 1 illustrate that for BP, upregulated genes were mainly enriched in translational elongation and translation; downregulated genes were largely enriched in positive regulation of response to the stimulus, positive regulation of immune system process, immune response, activation of the immune response, response to wounding and lymphocyte mediated immunity. For CC, enrichment of upregulated genes was primarily in the cytosolic ribosome, ribosomal subunit, and cytosolic part, and that of downregulated genes was mainly in the extracellular region part. Upregulated genes in MF are mainly involved in structural constituents of ribosome and structural molecule activity and the downregulated genes mainly in Ras guanyl-nucleotide exchange factor activity. 
| Signaling pathway enrichment analysis
| Immune analysis of downregulated DEGs
Based on the above results, we found the downregulated DEGs to be significantly associated with the immune system. Therefore, we performed the interrelation analysis by assessing the immune system and CD9 (Belloni et al., 2018; De Bruyne et al., 2008) , leading to progression of MM.
| PPI construction and modular analysis
DEGs in CC are mainly enriched in cytosolic ribosomes.
Consistent with this, DEGs in MF are mainly associated with the structural constituents of ribosomes. Ribosome biogenesis is a process by which ribosomes are generated for protein synthesis, and this process is critical for cells to survive, grow and proliferate (Iadevaia, Liu, & Proud, 2014; Lessard, Brakier-Gingras, & Ferbeyre, 2019 this pathway was found to be the most significant pathway in another MM polygenic interaction study (Chattopadhyay et al., 2018) . The NF-kappa B signaling pathway plays a crucial role in the proliferation, survival and treatment resistance of MM, and dysregulation of NF-kB may result from genetic and microenvironment-driven mechanisms (Demchenko et al., 2010; Keats et al., 2007; McMillin et al., 2010) .
Furthermore, important therapeutic advances have emerged through alteration of the activity of NF-kB with pharmacological interventions (Adams, 2004; Moreau et al., 2012) . The three subtypes of PPAR (PPARalpha, beta/delta, and gamma) exhibit differential expression patterns in vertebrates. PPARγ agonists significantly suppress the adhesive interaction between MM and bone marrow stromal cells (Wang, Yang, Zhang, & Farrar, 2007) and increase the cytotoxic effect of other drugs in MM cells (Aouali et al., 2009) . (Rawstron et al., 1998) , deregulation of the T cell compartment (Koike et al., 2002) , upregulation of inhibitory ligands (Paiva et al., 2015) , disruption of antigen presentation (Brown, Pope, Yuen, Gibson, & Joshua, 1998) and recruitment of immunosuppressive cells (Franssen et al., 2015; Malek et al., 2016) . Thus, various immunotherapy strategies have been developed, such as immunomodulatory drugs, checkpoint inhibitors, monoclonal antibodies, chimeric antigen receptor T-cells, and vaccines (Kumar & Anderson, 2016;  Rodriguez-Otero, Paiva, Engelhardt, Prosper, & San Miguel, 2017) .
These strategies have shown encouraging results in patients with relapsed refractory MM and also in improving patient outcomes (Neri, Bahlis, & Lonial, 2016) .
A PPI network of DEGs was constructed, containing 94 nodes and 224 edges. In this network, screening revealed two significant modules based on the degree of importance. Many of the core genes within the subnetworks have been reported to play a crucial role in the development of MM, such as SYK, CD81, and CD9. SYK, a protein kinase, is a critical element in B cell receptor signaling (Knoll et al., 2017) . Moreover, SYK has been demonstrated to be involved in ectoenzyme CD38-, chemokine receptor CXCR4-, and integrin ligand VCAM1 signaling (Buchner et al., 2010) . CD38 is characteristically expressed on myeloma cells, and CXCR4 and VCAM1 play a crucial role in MM-microenvironmental crosstalk (Schuler, Ewerth, Waldschmidt, Wasch, & Engelhardt, 2013) . Targeting SYK has shown promising therapeutic effects in B cell malignancies, including chronic lymphoid leukemia (D. Liu & Mamorska-Dyga, 2017) , and in MM, inhibition of SYK resulted in significant decreases in cell survival and migration (Lorenz et al., 2016) . Previous studies have demonstrated that CD81 is an independent prognostic factor in MM and may be associated with MM pathogenesis (Arana et al., 2018; F. Chen et al., 2018; Paiva et al., 2017) . Expression of CD9 in MM cells is related to the disease status and survival of patients with MM, and CD9 was found to be involved in transendothelial invasion in an MM mouse model (De Bruyne et al., 2006) . Moreover, CD9 expression was found to be downregulated during disease progression, which led to decreased susceptibility of MM cells to NK cell-mediated cytolysis (De Bruyne et al., 2008) . Our survival analysis revealed 31 DEGs to be significantly associated with survival in MM patients, and further investigation of these genes in clinical research is warranted.
In conclusion, integrated bioinformatics analysis of multiple datasets of newly diagnosed MM patients and healthy controls was performed. Common DEGs were identified that are significantly enriched in various pathways, especially immune responses, followed by evaluation of the prognostic value for patients with MM. Notably, most of the prognostic genes are immune-related genes. The results of this study increase our understanding of the molecular drivers that underlie MM initiation and progression, and the critical genes and pathways identified constitute potential therapeutic targets.
